Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
2(20%)
Results Posted
14%(1 trials)
Terminated
1(10%)

Phase Distribution

Ph not_applicable
8
80%
Ph phase_1
1
10%
Ph phase_3
1
10%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
Phase 3Large-scale testing
1(10.0%)
N/ANon-phased studies
8(80.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(7)
Terminated(1)

Detailed Status

Completed7
Recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
87.5%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (10.0%)
Phase 31 (10.0%)
N/A8 (80.0%)

Trials by Status

recruiting220%
terminated110%
completed770%

Recent Activity

2 active trials
Showing 5 of 10
recruitingnot_applicable

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

NCT03887715
recruitingnot_applicable

Treatment Resistant Depression and Vagus Nerve Stimulation

NCT05952674
completednot_applicable

A Study to Evaluate the Effect of Vagus Nerve Stimulation in Patients Undergoing VT Ablation

NCT04359004
completednot_applicable

Autonomic Regulation Therapy in Heart Failure With Preserved Ejection Fraction

NCT03163030
completednot_applicable

VNS-induced Corticospinal Plasticity

NCT04088565
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT03887715Not Applicable

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

Recruiting
NCT05952674Not Applicable

Treatment Resistant Depression and Vagus Nerve Stimulation

Recruiting
NCT04359004Not Applicable

A Study to Evaluate the Effect of Vagus Nerve Stimulation in Patients Undergoing VT Ablation

Completed
NCT03163030Not Applicable

Autonomic Regulation Therapy in Heart Failure With Preserved Ejection Fraction

Completed
NCT04088565Not Applicable

VNS-induced Corticospinal Plasticity

Completed
NCT02243020Not Applicable

VNS During Rehabilitation for Improved Upper Limb Motor Function After Stroke

Completed
NCT01569503Phase 3

Vagus Nerve Stimulation a New Approach in the Treatment of Crohn's Disease

Terminated
NCT01253616Not Applicable

Proof-of-Concept Study Assessing VNS Paired With Tones for Tinnitus

Completed
NCT01823887Phase 1

Autonomic Neural Regulation Therapy to Enhance Myocardial Function in Heart Failure (ANTHEM-HF) Study

Completed
NCT00533832Not Applicable

Pivotal Trial (D02) of Vagus Nerve Stimulation (VNS) for Treatment-Resistant Depression (TRD)

Completed

All 10 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
10